This Week in HIV Research: When Prioritizing Treatment, Look Beyond CD4

This Week in HIV Research: When Prioritizing Treatment, Look Beyond CD4

1 of 5
Next >

Our whirlwind tour of recently published under-the-radar manuscripts on HIV-related issues addresses the following questions this week:

  • Among HIV-positive people with high CD4 counts, can lab tests help us spot who needs to start treatment most promptly?
  • Does coinfection with hepatitis C affect a woman's response to HIV treatment?
  • What do demographic trends mean for the future health care needs of HIV-positive people in Africa?
  • Could there be a relationship between an increase in PrEP prescriptions and the prevalence of drug-resistant gonorrhea?

Join us for a closer look. To beat HIV, you have to follow the science!

Image Credit: Kkolosov for iStock via Thinkstock

Our whirlwind tour of recently published under-the-radar manuscripts on HIV-related issues addresses the following questions this week:

  • Among HIV-positive people with high CD4 counts, can lab tests help us spot who needs to start treatment most promptly?
  • Does coinfection with hepatitis C affect a woman's response to HIV treatment?
  • What do demographic trends mean for the future health care needs of HIV-positive people in Africa?
  • Could there be a relationship between an increase in PrEP prescriptions and the prevalence of drug-resistant gonorrhea?

Join us for a closer look. To beat HIV, you have to follow the science!

Image Credit: Kkolosov for iStock via Thinkstock